UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Medline ® Abstract for Reference 42

of 'Extravasation injury from chemotherapy and other non-antineoplastic vesicants'

42
TI
Revisions to the 2009 american society of clinical oncology/oncology nursing society chemotherapy administration safety standards: expanding the scope to include inpatient settings.
AU
Jacobson JO, Polovich M, Gilmore TR, Schulmeister L, Esper P, Lefebvre KB, Neuss MN
SO
J Oncol Pract. 2012 Jan;8(1):2-6. Epub 2011 Dec 13.
 
In November 2009, ASCO and the Oncology Nursing Society (ONS) jointly published a set of 31 voluntary chemotherapy safety standards for adult patients with cancer, as the end result of a highly structured, multistakeholder process. The standards were explicitly created to address patient safety in the administration of parenteral and oral chemotherapeutic agents in outpatient oncology settings. In January 2011, a workgroup consisting of ASCO and ONS members was convened to review feedback received since publication of the standards, to address interim changes in practice, and to modify the standards as needed. The most significant change to the standards is to extend their scope to the inpatient setting. This change reflects the conviction that the same standards for chemotherapy administration safety should apply in all settings. The proposed set of standards has been approved by the Board of Directors for both ASCO and ONS and has been posted for public comment. Comments were used as the basis for final editing of the revisedstandards. The workgroup recognizes that the safety of oral chemotherapy usage, nononcology medication reconciliation, and home chemotherapy administration are not adequately addressed in the original or revised standards. A separate process, cosponsored by ASCO and ONS, will address the development of safety standards for these areas.
AD
Dana Farber Cancer Institute, Boston MA; Duke Oncology Network, Durham, NC; American Society of Clinical Oncology, Alexandria, VA; Oncology Nursing Consultant, New Orleans, LA; University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; Oncology Nursing Society, Pittsburgh, PA; and Oncology Hematology Care, Cincinnati, OH.
PMID